Stock Price
33.44
Daily Change
-0.28%
Yearly
-28.92%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 21.85 -0.08 -0.36% -55.05%
Agios Pharmaceuticals 31.83 0.31 0.98% -33.74%
Alnylam Pharmaceuticals 130.94 -5.59 -4.09% -25.47%
Amgen 226.33 1.29 0.57% -12.48%
Amarin 3.57 0.31 9.36% -51.43%
Aptinyx Inc 3.28 0.27 8.97% -15.90%
Arena Pharmaceuticals 89.89 -0.06 -0.07% 15.24%
Baxter International 85.39 0.32 0.38% 5.67%
Cara Therapeutics 11.92 0.13 1.10% -37.85%
Cytokinetics 31.21 0.73 2.40% 54.12%
DBV Technologies 1.52 0.01 0.66% -71.48%
Esperion Therapeutics 4.20 0.15 3.70% -88.01%
Five Prime Therapeutics 38.00 0 0% 1,339.39%
Halozyme Therapeutics 33.44 -0.10 -0.28% -28.92%
Intercept Pharmaceuticals 15.65 0.27 1.76% -58.54%
Immunogen 5.45 0.05 0.83% -28.82%
Ionis Pharmaceuticals 31.48 0.08 0.25% -50.64%
Intra Cellular Therapies 47.52 0.88 1.88% 48.53%
Jazz Pharmaceuticals 133.58 2.54 1.93% -19.56%
Eli Lilly 241.92 2.46 1.03% 16.55%
MannKind 3.75 0.07 1.77% 5.34%
Minerva Neurosciences 0.73 -0.03 -3.95% -78.84%
Nektar Therapeutics 10.90 -0.28 -2.50% -38.56%
Pfizer 53.43 0.89 1.69% 43.21%
Peregrine Pharmaceuticals 17.78 -0.59 -3.21% 20.95%
Rigel Pharmaceuticals 2.45 0.02 0.82% -30.79%
United Therapeutics 199.72 -2.43 -1.20% 17.93%
Vanda Pharmaceuticals 14.78 0.13 0.85% 2.68%
Intrexon 2.90 0.10 3.57% -67.42%

Indexes Price Day Year
NASDAQ 13876 336.49 2.49% 4.56%
US2000 2046 41.75 2.08% -2.98%

Halozyme Therapeutics
Halozyme Therapeutics, Inc. is a biopharma technology platform company. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds. The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. The Company's approved product and its collaborators’ approved products and product candidates are based on rHuPH20, a patented recombinant human hyaluronidase enzyme. The Company's lead product, Hylenex recombinant, is a formulation of rHuPH20 that facilitates subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs and, in subcutaneous urography, to improve resorption of radiopaque agents. Its pipeline products include Herceptin SC, HYQVIA, DARZALEX and others.